PMGC(ELAB.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
PMGC
ELAB.US
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company’s lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc.
534.89 B
ELAB.USMarket value -Rank by Market Cap -/-

Financial Score

29/01/2026 Update
C
Personal Care ProductsIndustry
Industry Ranking38/55
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-76.20%E
    • Profit Margin-2343.04%E
    • Gross Margin-82.03%E
  • Growth ScoreB
    • Revenue YoY128.20%A
    • Net Profit YoY-22.51%D
    • Total Assets YoY33.31%A
    • Net Assets YoY-0.75%D
  • Cash ScoreB
    • Cash Flow Margin-4.27%D
    • OCF YoY128.20%A
  • Operating ScoreE
    • Turnover0.02E
  • Debt ScoreC
    • Gearing Ratio43.16%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    PMGC Holdings Raises $5 Million in Private Share Sale

    PMGC Holdings Inc. has raised $5 million through a secured pre-paid equity purchase, marking its third such transaction. The company received gross proceeds of $5 million, with net proceeds totaling $4,562,840 after fees. The investor can require share issuance at 88% of the lowest VWAP over the last ten trading days, with ownership limitations and accelerated repayment provisions in case of default. This announcement was published via EDGAR on January 20, 2026.

    Reuters·
    US
    IBB
    +0.40%
    US
    XBI
    +0.96%
    US
    ELAB
    +1.32%
    Reuters·
    US
    IBB
    +0.40%
    US
    XBI
    +0.96%
    US
    ELAB
    +1.32%

    Top 3 Risk Off Stocks That could Lead To Your Biggest Gains This Quarter

    The consumer staples sector shows potential for gains with oversold stocks. Key players include Oddity Tech Ltd (NASDAQ:ODD) with an RSI of 25.3, PMGC Holdings Inc (NASDAQ:ELAB) at 16.2, and Zevia Pbc (NYSE:ZVIA) at 26. Analysts maintain positive ratings despite recent stock declines. ODD's price target is lowered to $50, ELAB's stock fell 73%, and ZVIA's target remains at $6. These stocks may present buying opportunities for investors looking for undervalued assets.

    benzinga_article·
    US
    ELAB
    +1.32%
    US
    ODD
    +0.73%
    US
    TGT
    +0.84%
    benzinga_article·
    US
    ELAB
    +1.32%
    US
    ODD
    +0.73%
    US
    TGT
    +0.84%

    PMGC Holdings Signs Secured Pre-Paid Equity Purchase With Investor

    PMGC Holdings has signed a Secured Pre-Paid Equity Purchase agreement to enhance liquidity, involving a $3.28 million principal with a $278,700 discount, yielding $3.0 million in upfront proceeds. The agreement allows for share issuances at 88% of the lowest 10-day VWAP, with a 9.99% ownership cap, and a prepayment option at 120% of the outstanding balance. The agreement is effective from January 7, 2026, and matures on January 7, 2029.

    TradingView·
    US
    ELAB
    +1.32%
    TradingView·
    US
    ELAB
    +1.32%

    Pre-market hot trades in US stocks: PMGC pre-market down 7.54%; Regencell Bioscience pre-market down 4.78%

    PMGC pre-market down 7.54%; Regencell Bioscience pre-market down 4.78%; DIGITAL ALLY INC pre-market up 58.45%; La Rosa pre-market up 39.74%; Offerpad Solutions pre-market up 38.82%

    Tracking Unusual Activity·
    US
    ELAB
    +1.32%
    US
    RGC
    -5.45%
    Tracking Unusual Activity·
    US
    ELAB
    +1.32%
    US
    RGC
    -5.45%

    U.S. stock market movement report: Alumis surges 150%, Mobix Labs plummets 46%, tech stocks trading actively

    Overview of the US Stock Market In the past hour, the US stock market has shown significant sector rotation, with technology and pharmaceutical sectors performing particularly well. Capital flows have clearly favored small-cap stocks and thematic stocks, especially those companies with major news or technological breakthroughs recently. Market sentiment is active, with considerable volatility, and short-term enthusiasm continues to rise. The stock with the largest movement, Alumis, leads the market with a 150.64% increase, and trading volume has significantly expanded, indicating strong investor confidence in its future development. The strong performance of this stock may be related to its innovative breakthroughs in the pharmaceutical field, attracting substantial capital attention. Strong stocks: 1. Autozi Internet Tech Global: up 51.24%, with increased trading volume, driven by the enthusiasm in the technology sector pushing its stock price significantly higher. 2. PMGC: up 31.37%, with noticeable capital inflow, and the market is optimistic about its future growth expectations. 3. Brand Engagement Network: up 29.94%, with active short-term capital and high market sentiment. 4. WAVE Life Sciences: up 27.40%, driven by the strong performance of the pharmaceutical sector pushing its stock price upward. 5. Sky Quarry: up 26.15%, with increased attention on environmental themes driving the stock price up. 6. Banzai: up 22.29%, with increased market recognition of its business model and noticeable capital inflow

    Tracking Unusual Activity·
    US
    ELAB
    +1.32%
    US
    RGC
    -5.45%
    Tracking Unusual Activity·
    US
    ELAB
    +1.32%
    US
    RGC
    -5.45%
    © 2026 Longbridge｜Disclaimer